Salih Ehsan/LinkedIn
Sep 15, 2026, 08:13
Salih Ehsan: Unraveling the Complex Phenotypes of TDT and NTDT
Salih Ehsan, Chief Executive Officer at Kulsoom Society of Hematology, shared a post on LinkedIn:
“TDTs and NTDTs phenotypes are complex entities, to understand them need a detective work about patient, parents and available close family members ( details history, examination, blood transfusion history of all family members, history of oral or iv iron trails failure, partial effect of oral folic acid or IM B12 , CBC with thalassemia signature, HPLC finding and then decision about molecular testing – a Gold standard) , I try my best to give the taste of both phenotypes.” 
Find more posts featuring Salih Ehsan on Hemostasis Today.
-
Sep 15, 2026, 07:52Tammuella Chrisentery-Singleton: Honored to Present at AHAD-AP Bangkok
-
Sep 15, 2026, 07:38Aaron Paul Kithcart: Connecting Science and Collaboration in Nagasaki
-
Sep 15, 2026, 02:59Caterina Casari: Curious about How Gene Editing is Revolutionizing Our Field?
-
Sep 15, 2026, 02:53Alejandro González Veliz: Can Lifestyle Changes Actually Reverse Atherosclerosis?
-
Sep 15, 2026, 02:08Eugenia Gianos: ACC CVPrevention Council’s New Statin Resources
-
Sep 15, 2026, 01:58Shinya Goto: Country Specific Randomized Trial Show the Merit of DOAC in Intermediate Risk of A
-
Sep 15, 2026, 01:37Lesley Van Wyk: Exploring Sickle Cell Disease – The HbS Story
-
Sep 15, 2026, 01:31Luca Seffin: To the Science, the People, and the Journey – Thank You SR-Tiget
-
Sep 14, 2026, 23:49Heghine Khachatryan: New evidance – Antiphospholipid Antibodies and Ischemic Stroke